Patient Controlled Analgesia Pumps Market By Type, By Application, By End user : Global Opportunity Analysis and Industry Forecast, 2021-2031

List of Tables

The patient controlled analgesia pumps market size valued for $277.67 million in 2021 and is estimated to reach $407.89 million by 2031, exhibiting a CAGR of 3.9% from 2022 to 2031.

Patient-controlled analgesia (PCA) is an effective pain management technique that offers the patient control over their pain. These pumps deliver opioid painkillers such hydromorphone, fentanyl, and morphine. The pump is attached to an intravenous (IV) line, which is a small, flexible tube inserted into a vein. Normally, this medication is administered when the button is pressed. These pumps are medical devices that deliver the medications into a patient's body in controlled amounts. Analgesic pumps are increasingly used in clinical settings such as hospitals, nursing homes, and in home. The applications of these analgesic pumps for delivery of medications such as morphine, fentanyl and hydromorphone. The PCA pump have the advantages such as safe to use, patient satisfaction, less sedation, reduced medication, and the nursing team is informed by an alert when the pump is empty.

PCA is equipped with a computerized pump, which is often used by patients recovering from surgery. It is employed for post-operative management. It is a method of pain control that provides patients with the power to control their pain. In addition, PCA is beneficial for patients who find difficulty in consuming medication by mouth. In some cases, the dose is set and an additional dose can be administered by patients themselves just by pressing a button. The patient-controlled analgesia can be administered by various routes, including oral, intravenous, epidural, inhaled, nasal spray, and transcutaneous.

Patient controlled analgesia pumps are used to treat acute, chronic, postoperative, and labor pain, particularly in individuals who are unable to receive oral medications. In cases of acute pain in which the initial opioid dose in urgent care was insufficient to relieve pain thus, patient-controlled analgesia pumps can be useful. Some examples of common cases include burns, trauma, pancreatitis, and vaso-occlusive pain crises.

The growth of global patient controlled analgesia pumps market is majorly driven by increase in demand for analgesic pumps to relieve the pain such as cancer pain, orthopedic, and sickle cell crises pain, rise in number of surgical procedures which requires the analgesic pumps. However, lack of knowledge regarding advanced patient controlled analgesic pumps in emerging countries and regulations for product approval hinders the market growth. Conversely, increase in demand for patient controlled analgesic pumps and rise in technological advancements in analgesic pumps are anticipated to provide lucrative opportunities to the market players. The possibility of medication errors exists due to increase in disease burden. Thus, there is a need for advanced delivery systems that are safer, more efficient, and standardized. In addition, the introduction of advanced PCA pumps provides the lucrative growth opportunities for the market.

Factors such as surge in geriatric population, rise in prevalence of chronic pain, and low cost are likely to propel the market. Moreover, rise in the number of individuals undergoing surgeries globally for cancer, or other ailments is likely to have a positive impact on the market growth. Rise in incidence of diseases such as cancer, sickle cell disease, and orthopedics has led to an increase in demand for patient controlled analgesic pump devices. For instance, according to the Centers for Disease Control and Prevention (CDC), estimated that approximately 100,000 Americans affected with sickle cell disease in May 2022. Thus, rise in prevalence of sickle cell disease has increased the uptake for PCA pumps and thus drives the market growth.

The global patient controlled analgesia pumps market is segmented into type, application, end user, and region. By type, the market is categorized into electronic & wireless and mechanical. On the basis of application, the market is segregated into oncology & hematology, gastroenterology, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major Key players that operate in the global patient controlled analgesia pumps market are: Ace-medical, Arcomed AG, B. Braun SE, Becton, Dickinson and Company, Changzhou Medical Bioengineering Co., Ltd., Fresenius SE and Co. KGaA, Henan Tuoren Medical Device Co., Ltd., ICU Medical, Inc., Micrel Medical Devices SA, SCW Medicath Ltd.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the patient controlled analgesia pumps market analysis from 2021 to 2031 to identify the prevailing patient controlled analgesia pumps market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the patient controlled analgesia pumps market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global patient controlled analgesia pumps market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

Electronic and Wireless
Mechanical

By Application

Oncology and hematology
Gastroenterology
Others

By End user

Hospitals
Ambulatory surgical centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players

Ace-medical
B. Braun SE
ICU Medical, Inc.
SCW Medicath Ltd
Changzhou Medical Bioengineering Co., Ltd.
Arcomed AG
Becton, Dickinson and Company
Henan Tuoren Medical Device Co., Ltd.
Fresenius SE and Co. KGaA
Micrel Medical Devices SA

Product Code: A13386

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate bargaining power of buyers
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate threat of new entrants
- 3.3.5. Moderate intensity of rivalry
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Rise in cases of chronic pain diseases
  - 3.4.1.2. Technological advancements in analgesic pumps
  - 3.4.1.3. Increase in number of surgeries
- 3.4.2. Restraints
  - 3.4.2.1. Lack of awareness regarding analgesia pumps
  - 3.4.2.2. Stringent government regulations
- 3.4.3. Opportunities
  - 3.4.3.1. Lucrative growth opportunities in developing countries
  - 3.4.3.2. Development in analgesic pumps
3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Electronic and Wireless
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Mechanical
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country

CHAPTER 5: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Oncology and hematology
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Gastroenterology
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Others
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country

CHAPTER 6: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Ambulatory surgical centers
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country

CHAPTER 7: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Type
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by End user
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Key market trends, growth factors and opportunities
  - 7.2.5.1.2. Market size and forecast, by Type
  - 7.2.5.1.3. Market size and forecast, by Application
  - 7.2.5.1.4. Market size and forecast, by End user
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Key market trends, growth factors and opportunities
  - 7.2.5.2.2. Market size and forecast, by Type
  - 7.2.5.2.3. Market size and forecast, by Application
  - 7.2.5.2.4. Market size and forecast, by End user
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Key market trends, growth factors and opportunities
  - 7.2.5.3.2. Market size and forecast, by Type
  - 7.2.5.3.3. Market size and forecast, by Application
  - 7.2.5.3.4. Market size and forecast, by End user
7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Type
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by End user
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Key market trends, growth factors and opportunities
  - 7.3.5.1.2. Market size and forecast, by Type
  - 7.3.5.1.3. Market size and forecast, by Application
  - 7.3.5.1.4. Market size and forecast, by End user
  - 7.3.5.2. France
  - 7.3.5.2.1. Key market trends, growth factors and opportunities
  - 7.3.5.2.2. Market size and forecast, by Type
  - 7.3.5.2.3. Market size and forecast, by Application
  - 7.3.5.2.4. Market size and forecast, by End user
  - 7.3.5.3. UK
  - 7.3.5.3.1. Key market trends, growth factors and opportunities
  - 7.3.5.3.2. Market size and forecast, by Type
  - 7.3.5.3.3. Market size and forecast, by Application
  - 7.3.5.3.4. Market size and forecast, by End user
  - 7.3.5.4. Italy
  - 7.3.5.4.1. Key market trends, growth factors and opportunities
  - 7.3.5.4.2. Market size and forecast, by Type
  - 7.3.5.4.3. Market size and forecast, by Application
  - 7.3.5.4.4. Market size and forecast, by End user
  - 7.3.5.5. Spain
  - 7.3.5.5.1. Key market trends, growth factors and opportunities
  - 7.3.5.5.2. Market size and forecast, by Type
  - 7.3.5.5.3. Market size and forecast, by Application
  - 7.3.5.5.4. Market size and forecast, by End user
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Key market trends, growth factors and opportunities
  - 7.3.5.6.2. Market size and forecast, by Type
  - 7.3.5.6.3. Market size and forecast, by Application
  - 7.3.5.6.4. Market size and forecast, by End user
7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Type
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by End user
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. Japan
  - 7.4.5.1.1. Key market trends, growth factors and opportunities
  - 7.4.5.1.2. Market size and forecast, by Type
  - 7.4.5.1.3. Market size and forecast, by Application
  - 7.4.5.1.4. Market size and forecast, by End user
  - 7.4.5.2. China
  - 7.4.5.2.1. Key market trends, growth factors and opportunities
  - 7.4.5.2.2. Market size and forecast, by Type
  - 7.4.5.2.3. Market size and forecast, by Application
  - 7.4.5.2.4. Market size and forecast, by End user
  - 7.4.5.3. India
  - 7.4.5.3.1. Key market trends, growth factors and opportunities
  - 7.4.5.3.2. Market size and forecast, by Type
  - 7.4.5.3.3. Market size and forecast, by Application
  - 7.4.5.3.4. Market size and forecast, by End user
  - 7.4.5.4. Australia
  - 7.4.5.4.1. Key market trends, growth factors and opportunities
  - 7.4.5.4.2. Market size and forecast, by Type
  - 7.4.5.4.3. Market size and forecast, by Application
  - 7.4.5.4.4. Market size and forecast, by End user
  - 7.4.5.5. South Korea
  - 7.4.5.5.1. Key market trends, growth factors and opportunities
  - 7.4.5.5.2. Market size and forecast, by Type
  - 7.4.5.5.3. Market size and forecast, by Application
  - 7.4.5.5.4. Market size and forecast, by End user
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Key market trends, growth factors and opportunities
  - 7.4.5.6.2. Market size and forecast, by Type
  - 7.4.5.6.3. Market size and forecast, by Application
  - 7.4.5.6.4. Market size and forecast, by End user
7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Type
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by End user
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Key market trends, growth factors and opportunities
  - 7.5.5.1.2. Market size and forecast, by Type
  - 7.5.5.1.3. Market size and forecast, by Application
  - 7.5.5.1.4. Market size and forecast, by End user
  - 7.5.5.2. Saudi Arabia
  - 7.5.5.2.1. Key market trends, growth factors and opportunities
  - 7.5.5.2.2. Market size and forecast, by Type
  - 7.5.5.2.3. Market size and forecast, by Application
  - 7.5.5.2.4. Market size and forecast, by End user
  - 7.5.5.3. South Africa
  - 7.5.5.3.1. Key market trends, growth factors and opportunities
  - 7.5.5.3.2. Market size and forecast, by Type
  - 7.5.5.3.3. Market size and forecast, by Application
  - 7.5.5.3.4. Market size and forecast, by End user
  - 7.5.5.4. Rest of LAMEA
  - 7.5.5.4.1. Key market trends, growth factors and opportunities
  - 7.5.5.4.2. Market size and forecast, by Type
  - 7.5.5.4.3. Market size and forecast, by Application
  - 7.5.5.4.4. Market size and forecast, by End user

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

9.1. Ace-medical
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
9.2. Arcomed AG
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
9.3. B. Braun SE
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
9.4. Becton, Dickinson and Company
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
9.5. Henan Tuoren Medical Device Co., Ltd.
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
9.6. ICU Medical, Inc.
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
- 9.6.7. Key strategic moves and developments
9.7. Micrel Medical Devices SA
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
9.8. Fresenius SE and Co. KGaA
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business performance
9.9. Changzhou Medical Bioengineering Co., Ltd.
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
9.10. SCW Medicath Ltd
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio